Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 8 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Cullinan Therapeutics, Inc. | 8,963,500 | reported | 28 Oct 2025 | tx 1+165,667 |
| TScan Therapeutics, Inc. | 7,500,000 | reported | 26 Dec 2024 | tx 4+7,632,747 |
| Passage BIO, Inc. | 623,704 | reported | 15 Sept 2025 | tx 3+32,008 |
| Crinetics Pharmaceuticals, Inc. | 16,300 | reported | 11 Jun 2025 | tx 10+116,650 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 Oct 2025 | PURCHASE | Cullinan Therapeutics, Inc. | 165,667 | 8.40 USD | |
| 15 Sept 2025 | PURCHASE | Passage BIO, Inc. | 11,900 | 6.99 USD | |
| 11 Sept 2025 | PURCHASE | Passage BIO, Inc. | 325 | 6.96 USD | |
| 12 Sept 2025 | PURCHASE | Passage BIO, Inc. | 19,783 | 6.99 USD | |
| 11 Jun 2025 | GRANT_AWARD | Crinetics Pharmaceuticals, Inc. | 6,900 | 0.00 USD | |
| 11 Jun 2025 | GRANT_AWARD | Crinetics Pharmaceuticals, Inc. | 10,350 | 0.00 USD | deriv |
| 26 Dec 2024 | PURCHASE | TScan Therapeutics, Inc. | 7,500,000 | 4.00 USD | deriv |
| 13 Dec 2024 | PURCHASE | TScan Therapeutics, Inc. | 100,000 | 2.90 USD | |
| 12 Dec 2024 | PURCHASE | TScan Therapeutics, Inc. | 31,800 | 3.01 USD | |
| 15 Nov 2024 | PURCHASE | TScan Therapeutics, Inc. | 947 | 4.34 USD | |
| 07 Jun 2024 | GRANT_AWARD | Crinetics Pharmaceuticals, Inc. | 3,400 | 0.00 USD | |
| 07 Jun 2024 | GRANT_AWARD | Crinetics Pharmaceuticals, Inc. | 12,500 | 0.00 USD | deriv |
| 16 Jun 2023 | GRANT_AWARD | Crinetics Pharmaceuticals, Inc. | 6,000 | 0.00 USD | |
| 16 Jun 2023 | GRANT_AWARD | Crinetics Pharmaceuticals, Inc. | 17,500 | 0.00 USD | deriv |
| 17 Jun 2022 | GRANT_AWARD | Crinetics Pharmaceuticals, Inc. | 17,500 | 0.00 USD | deriv |
| 22 Jun 2021 | GRANT_AWARD | Crinetics Pharmaceuticals, Inc. | 17,500 | 0.00 USD | deriv |
| 19 Jun 2020 | GRANT_AWARD | Crinetics Pharmaceuticals, Inc. | 12,500 | 0.00 USD | deriv |
| 21 Jun 2019 | GRANT_AWARD | Crinetics Pharmaceuticals, Inc. | 12,500 | 0.00 USD | deriv |